Immune attack: the role of inflammation in Alzheimer disease.

Autor: Heppner FL; 1] Department of Neuropathology, Charitéplatz 1, Charité - Universitätsmedizin Berlin, D-10117 Berlin, Germany. [2] Cluster of Excellence, NeuroCure, Charitéplatz 1, D-10117 Berlin, Germany., Ransohoff RM; Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, USA., Becher B; Institute of Experimental Immunology, University of Zürich, Winterthurerstrasse 190, CH-8057 Zrich, Switzerland.
Jazyk: angličtina
Zdroj: Nature reviews. Neuroscience [Nat Rev Neurosci] 2015 Jun; Vol. 16 (6), pp. 358-72.
DOI: 10.1038/nrn3880
Abstrakt: The past two decades of research into the pathogenesis of Alzheimer disease (AD) have been driven largely by the amyloid hypothesis; the neuroinflammation that is associated with AD has been assumed to be merely a response to pathophysiological events. However, new data from preclinical and clinical studies have established that immune system-mediated actions in fact contribute to and drive AD pathogenesis. These insights have suggested both novel and well-defined potential therapeutic targets for AD, including microglia and several cytokines. In addition, as inflammation in AD primarily concerns the innate immune system - unlike in 'typical' neuroinflammatory diseases such as multiple sclerosis and encephalitides - the concept of neuroinflammation in AD may need refinement.
Databáze: MEDLINE
Externí odkaz: